Back to top

marijuana: Archive

Sundeep Ganoria

Cannabis Stock VRNOF Soars 178% in a Month: Time to Buy, Sell or Hold?

Verano's stock has surged 178% in a month on reform hopes, but pricing pressure and stiff competition test its momentum.

ACBNegative Net Change GTBIFNegative Net Change VRNOFPositive Net Change CURLFNegative Net Change

Sundeep Ganoria

3 Cannabis Stocks to Watch After Trump's Marijuana Rescheduling Signal

Trump's marijuana rescheduling remarks reignite cannabis optimism, putting Village Farms, Canopy Growth and High Tide in focus.

CGCNegative Net Change VFFPositive Net Change HITIPositive Net Change

Sweta Killa

Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification

Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.

MJNegative Net Change CGCNegative Net Change TLRYNegative Net Change ACBNegative Net Change YOLONo Net Change CNBSNegative Net Change MSOSNegative Net Change WEEDNegative Net Change

Sundeep Ganoria

Can Cannabis Stocks Reverse Their Prolonged Downtrend?

Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.

CRBPNegative Net Change CGCNegative Net Change TLRYNegative Net Change HRMYNegative Net Change GTBIFNegative Net Change

Sundeep Ganoria

Should You Buy, Hold or Sell TLRY Stock Post Q4 Earnings Release?

Tilray posts record non-cannabis revenues in fiscal 2025, but Q4 sales slip as cannabis weakness pressures overall results.

CGCNegative Net Change TLRYNegative Net Change ACBNegative Net Change CURLFNegative Net Change

Sundeep Ganoria

Cannabis Operator CRLBF Plans California Exit: How to Play the Stock?

Cresco plans to exit California, citing tough market dynamics, as it sharpens focus on high-margin growth markets.

TLRYNegative Net Change GTBIFNegative Net Change CRLBFPositive Net Change CURLFNegative Net Change

Sundeep Ganoria

Cannabis Operator Green Thumb Down 30% YTD: Time to Buy, Sell or Hold?

GTBIF slides 30% YTD as rising costs, flat revenues and tight U.S. rules weigh on margins and investor sentiment.

ACBNegative Net Change GTBIFNegative Net Change CRLBFPositive Net Change CURLFNegative Net Change

Sundeep Ganoria

Cannabis Stock Cresco Labs Plunges 24% YTD: Time to Sell or Hold?

CRLBF is down 24% YTD as U.S.-only exposure, falling margins and tighter regulations weigh on its cannabis business.

CGCNegative Net Change TLRYNegative Net Change ACBNegative Net Change CRLBFPositive Net Change

Sundeep Ganoria

Here's Why Harmony Biosciences Is an Unconventional Cannabis Investment

HRMY isn't your typical cannabis play - its synthetic CBD gel targets rare brain disorders with no approved therapies.

JAZZPositive Net Change AXSMNegative Net Change HRMYNegative Net Change

Sundeep Ganoria

Cannabis Operator Curaleaf Plunges 46% YTD: Time to Sell or Hold?

CURLF dives 46% YTD as domestic headwinds outweigh global growth; is it time to cash out or wait for a rebound?

CGCNegative Net Change TLRYNegative Net Change ACBNegative Net Change CURLFNegative Net Change

Sundeep Ganoria

Could the New Federal Bill Derail the U.S. Hemp Industry?

A proposed federal bill could upend the U.S. hemp market, threatening CBD and Delta-8 products now sold nationwide.

CGCNegative Net Change TLRYNegative Net Change CURLFNegative Net Change

Sundeep Ganoria

Cannabis Stock CGC Rallies 39% in Three Months: Time to Buy or Sell?

Canopy Growth surges 39% in three months as restructuring, margin gains and debt cuts renew investor interest.

CGCNegative Net Change TLRYNegative Net Change ACBNegative Net Change VFFPositive Net Change

Sundeep Ganoria

Cannabis Operator VFF Sells Fresh Produce Unit: How to Play the Stock?

After dropping its produce business, Village Farms sharpens its cannabis focus - boosting exports, margins and market share.

CGCNegative Net Change TLRYNegative Net Change ACBNegative Net Change VFFPositive Net Change

Sundeep Ganoria

Aurora Cannabis Stock Rises 30% YTD: Time to Buy or Sell?

ACB's 30% YTD rally reflects Q3 strength, but flat EPS estimates and consumer weakness keep analysts cautious about long-term upside.

CGCNegative Net Change TLRYNegative Net Change ACBNegative Net Change

Sundeep Ganoria

3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies

NVO, CRBP and SKYE are tapping into the booming obesity market with novel CBD-based therapies, offering alternatives amid intensifying GLP-1 competition.

NVOPositive Net Change LLYPositive Net Change CRBPNegative Net Change SKYEPositive Net Change

Sundeep Ganoria

Is Small-Cap Corbus Pharma a Worthy Cannabis Investment?

While CRBP's pipeline shows promise, the company's lack of marketed products remains a concern.

SNYNegative Net Change NVOPositive Net Change CRBPNegative Net Change

Sundeep Ganoria

Cannabis Stock Tilray Brands Loses 19% in a Month: Time to Sell or Hold?

TLRY's pivot into beverages shows promise, but with falling cannabis sales and delisting risks, we recommend staying on the sidelines for now.

PMPositive Net Change JAZZPositive Net Change CRBPNegative Net Change TLRYNegative Net Change

Zacks Equity Research

JAZZ Misses Q1 Earnings & Sales Estimates, Cuts '25 EPS Outlook

Jazz reports dismal first-quarter results. The company revises its 2025 EPS guidance to account for the recently completed Chimerix acquisition.

JAZZPositive Net Change PBYIPositive Net Change NTLANegative Net Change

Zacks Equity Research

IIPR's Q1 Earnings Coming Up: Key Factors to Impact the Stock

IIPR's Q1 2025 results may be impacted by property repossessions/sales, rent deferrals and partial tenant payments.

IIPRPositive Net Change LAMRPositive Net Change EPRNegative Net Change

Sundeep Ganoria

Buy, Sell or Hold JAZZ Stock? Key Tips Ahead of Q1 Earnings

Investors will likely focus on the sales performance of Jazz Pharmaceuticals' key neuroscience drugs, Xywav and Rylaze, when it reports Q1 results next week.

JAZZPositive Net Change AMRXPositive Net Change

Sundeep Ganoria

3 Unconventional Cannabis Stocks to Watch in 2025

Think cannabis investing is all hype? These three unconventional stocks could change your mind - and your portfolio - in 2025.

PMPositive Net Change JAZZPositive Net Change CRBPNegative Net Change

Sundeep Ganoria

Cardiol Therapeutics Stock: Is Cannabis Potential Priced In?

Cardiol Therapeutics shows promise with its CBD-based heart therapy, but a lack of approved drugs and a narrow pipeline raise red flags for cautious investors.

JAZZPositive Net Change KNSANegative Net Change CRDLNegative Net Change

Sundeep Ganoria

JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?

Both JAZZ and HRMY expect sales from neuroscience products to grow in 2025.

JAZZPositive Net Change HRMYNegative Net Change

Sundeep Ganoria

Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?

Not your typical cannabis play. Discover why Jazz Pharma's FDA-approved CBD drug could make it a top cannabis stock to watch in 2025.

JAZZPositive Net Change TLRYNegative Net Change

Sweta Killa

Best & Worst ETF Zones of Q1

We have highlighted three ETFs, each from the best and worst-performing zones in the first quarter of 2025.

EPOLNegative Net Change SGDMPositive Net Change WGMIPositive Net Change WEEDNegative Net Change EETHNegative Net Change BABOPositive Net Change